Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation

被引:448
作者
Lemere, CA
Blusztajn, JK
Yamaguchi, H
Wisniewski, T
Saido, TC
Selkoe, DJ
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,CTR NEUROL DIS,BOSTON,MA 02115
[2] BOSTON UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02215
[3] GUNMA UNIV,COLL MED CARE & TECHNOL,GUNMA,JAPAN
[4] NYU,MED CTR,DEPT NEUROL,NEW YORK,NY 10012
[5] TOKYO METROPOLITAN INST MED SCI,DEPT MOL BIOL,TOKYO 113,JAPAN
关键词
D O I
10.1006/nbdi.1996.0003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Patients with trisomy 21 [Down syndrome (DS)] progressively develop amyloid beta-protein (A beta) deposits and then other features of Alzheimer's disease (AD), apparently due to increased gene dosage and thus expression of the beta-amyloid precursor protein, Because the neuropathological phenotype in older DS subjects closely resembles that of AD, the examination of DS brains of increasing age provides a unique model of the progression of AD. Here, we characterized the deposition of several A beta peptides and apolipoprotein E in formalin-fixed brain sections from 29 DS subjects between 3 and 73 years old, Amyloid plaque number and the percentage of cortical area they occupied were quantified by computerized image analysis. A beta ending at amino acid 42 (A beta(42)) was the earliest form of A beta deposited in DS cortex, It was observed in 7 of 16 young (3-30 years) subjects, with the earliest deposition occurring at age 12. A beta ending at residue 40 (A beta(40)) was not detected until similar to age 30, a time when degenerating neurites around A beta immunoreactive (IR) plaques were first observed, and the frequency of A beta(40) IR plaques then rose with age, Even in old (51-73 years) DS subjects, A beta(42) IR plaques were always more abundant than A beta(40) IR plaques, A beta peptides starting at aspartate 1 or pyroglutamate 3 were detected in small subsets of compacted, neuritic plaques beginning around age 30 and rose with age, the latter species always exceeding the former, Thus, the N-termini of the A beta(42) peptides abundantly deposited in very young DS subjects remain unknown, Apo E was detectable in a small subset of A beta(42) in plaques beginning at age 12 and rose steadily with age; it clearly followed the deposition of A beta. Our analysis of very young DS brains suggests that amyloid plaque formation begins with A beta(42)-ending peptides, and the number and percentage of cortical area of A beta(42) plaques increase very little with advancing age, while other heterogeneous A beta species and Apo E progressively accrue onto plaques containing A beta(42). (C) 1996 Academic Press, Inc.
引用
收藏
页码:16 / 32
页数:17
相关论文
共 50 条
[1]   APOLIPOPROTEIN-E ALLELE EPSILON-4 IS LINKED TO INCREASED DEPOSITION OF THE AMYLOID BETA-PEPTIDE (A-BETA) IN CASES WITH OR WITHOUT ALZHEIMERS-DISEASE [J].
BERR, C ;
HAUW, JJ ;
DELAERE, P ;
DUYCKAERTS, C ;
AMOUYEL, P .
NEUROSCIENCE LETTERS, 1994, 178 (02) :221-224
[2]  
BURDICK D, 1992, J BIOL CHEM, V267, P546
[3]   APOLIPOPROTEIN-E IS A KINETIC BUT NOT A THERMODYNAMIC INHIBITOR OF AMYLOID FORMATION - IMPLICATIONS FOR THE PATHOGENESIS AND TREATMENT OF ALZHEIMER-DISEASE [J].
EVANS, KC ;
BERGER, EP ;
CHO, CG ;
WEISGRABER, KH ;
LANSBURY, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) :763-767
[4]   NONFIBRILLAR BETA-AMYLOID PROTEIN IS ASSOCIATED WITH SMOOTH-MUSCLE CELLS OF VESSEL WALLS IN ALZHEIMER-DISEASE [J].
FRACKOWIAK, J ;
ZOLTOWSKA, A ;
WISNIEWSKI, HM .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1994, 53 (06) :637-645
[5]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890
[6]   ISOLATION AND PARTIAL CHARACTERIZATION OF NEUROFIBRILLARY TANGLES AND AMYLOID PLAQUE CORE IN ALZHEIMERS-DISEASE - IMMUNOHISTOLOGICAL STUDIES [J].
GOREVIC, PD ;
GONI, F ;
PONSESTEL, B ;
ALVAREZ, F ;
PERESS, NS ;
FRANGIONE, B .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1986, 45 (06) :647-664
[7]  
GOWING E, 1994, J BIOL CHEM, V269, P10987
[8]   AMYLOID-BETA PROTEIN (A-BETA) IN ALZHEIMERS-DISEASE BRAIN - BIOCHEMICAL AND IMMUNOCYTOCHEMICAL ANALYSIS WITH ANTIBODIES SPECIFIC FOR FORMS ENDING AT A-BETA-40 OR A-BETA-42(43) [J].
GRAVINA, SA ;
HO, LB ;
ECKMAN, CB ;
LONG, KE ;
OTVOS, L ;
YOUNKIN, LH ;
SUZUKI, N ;
YOUNKIN, SG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) :7013-7016
[9]   APOLIPOPROTEIN-E EPSILON-4 AND CEREBRAL-HEMORRHAGE ASSOCIATED WITH AMYLOID ANGIOPATHY [J].
GREENBERG, SM ;
REBECK, GW ;
VONSATTEL, JPG ;
GOMEZISLA, T ;
HYMAN, BT .
ANNALS OF NEUROLOGY, 1995, 38 (02) :254-259
[10]   AMYLOID BETA-PEPTIDE IS PRODUCED BY CULTURED-CELLS DURING NORMAL METABOLISM [J].
HAASS, C ;
SCHLOSSMACHER, MG ;
HUNG, AY ;
VIGOPELFREY, C ;
MELLON, A ;
OSTASZEWSKI, BL ;
LIEBERBURG, I ;
KOO, EH ;
SCHENK, D ;
TEPLOW, DB ;
SELKOE, DJ .
NATURE, 1992, 359 (6393) :322-325